Role of Immunotherapy in the Management of Advanced Hepatocellular Carcinoma: A Systematic Review

医学 免疫疗法 肝细胞癌 恶性肿瘤 重症监护医学 肿瘤科 癌症 化疗 内科学
作者
Raja Narendra Divakar Addanki,Anjali Srikanth Mannava,Mustansir abbas ali,Hemasri Velmurugan,Pugazhenthan Thangaraju,Talagampala Sri Varshini
出处
期刊:Current Cancer Drug Targets [Bentham Science Publishers]
卷期号:25 (10): 1249-1259
标识
DOI:10.2174/0115680096309235240827052642
摘要

INTRODUCTION: The most prevalent histologic subtype of primary liver cancer, hepatocellular carcinoma, is also the third most lethal malignancy worldwide and a significant cause of cancer death. When diagnosed, it is frequently too late for curative therapies. To add to the difficulty, it is resistant to conventional systemic therapies like chemotherapy. METHODS: Recently, more attention has been given to the use of immunotherapy for this condition. Immunotherapy has had a major impact on the outcome of several malignancies; several studies have revealed the potential role of immunotherapy in advanced hepatocellular carcinoma. To provide an overview of the current literature, justification, and clinical evidence for the use of immunotherapy in advanced hepatocellular carcinoma, we employed a systematic literature review (SLR) approach in this work. Additionally, we explored the benefits and rationales of various treatment combinations and described the molecular mechanisms behind resistance to a number of immunotherapy drugs. RESULTS: A total of 188 articles from credible journals published between 2013 and August 7, 2023, were screened. Eight of those articles were chosen for in-depth study. This systematic review concluded that the current immunotherapeutic approaches have the potential to improve outcomes for aHCC patients; however, several clinical and biological hurdles have to be overcome, and predictive markers are still eagerly needed. CONCLUSION: To fully realize the potential of immunotherapy agents and their combination therapies to enhance health outcomes for patients with aHCC, additional investigation and research are required.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
可期完成签到,获得积分10
刚刚
小狗不悲伤完成签到,获得积分10
刚刚
Julian发布了新的文献求助80
刚刚
吴jie完成签到,获得积分10
1秒前
传奇3的应助被符聪采纳,获得10
2秒前
体贴夏柳完成签到,获得积分20
2秒前
2秒前
Jing完成签到,获得积分10
3秒前
科研通AI6.4的应助被xyx采纳,获得10
3秒前
3秒前
aticccu完成签到,获得积分10
3秒前
文乐完成签到,获得积分10
4秒前
NexusExplorer的应助被Nicole采纳,获得10
4秒前
wanci的应助被ZJJ35采纳,获得10
4秒前
thw完成签到 ,获得积分10
4秒前
4秒前
大力牌皮揣子完成签到 ,获得积分10
5秒前
meiko发布了新的文献求助10
5秒前
skotrie189完成签到,获得积分10
6秒前
科目三的应助被半斤酒才采纳,获得10
6秒前
rwddd发布了新的文献求助30
7秒前
Gauss完成签到,获得积分0
8秒前
8秒前
9秒前
9秒前
9秒前
9秒前
Jiang发布了新的文献求助10
9秒前
Clean完成签到,获得积分10
10秒前
10秒前
wangweisky发布了新的文献求助10
10秒前
11秒前
ll完成签到,获得积分10
11秒前
淋漓尽致完成签到,获得积分10
12秒前
ding的应助被达进采纳,获得10
12秒前
刘禹锡发布了新的文献求助10
12秒前
呆呆兔完成签到 ,获得积分10
12秒前
微笑发布了新的文献求助10
13秒前
星辰大海的应助被时静采纳,获得10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186261
求助须知:如何正确求助?哪些是违规求助? 9574697
关于积分的说明 21837731
捐赠科研通 7783915
什么是DOI,文献DOI怎么找? 3434752
关于科研通互助平台的介绍 2559109
邀请新用户注册赠送积分活动 2481528